PATENT CLAIM ANALYSIS

Application Number: 16000467
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
The invention relates to novel strategies for the treatment of cancer patients based on a combination of an opioid receptor agonist and an anticancer compound.

Claim (Index 22):
The method according  claim 21 , wherein said opioid receptor agonist is capable of inhibiting cell proliferation and/or inducing cell death.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10835511', '13338809', '15920486', '13907035', '14427426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7760648849761002
- 35 USC 102 Novelty (BERT): 0.5247056784223298
- Combined Prediction Score: 0.7509289643207232
- Mean Citation Score: 292.329026
- Max Citation Score: 308.32446
- Similarity Product: 184.09715959157467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test